Sensitization to amphetamine occurs simultaneously at immune level and in met-enkephalin of the nucleus accumbens and spleen: An involved NMDA glutamatergic mechanism

Brain, Behavior, and Immunity

Volumn 23, Issue 4, 2009, Pages 464-473

  Assis, María Amparo ^a   Hansen, Cristian ^a   Lux Lantos, Victoria ^b   Cancela, Liliana Marina ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

Amphetamine; Glutamate; Lymphoproliferative response; Met enkephalin; NMDA receptors; Sensitization

Indexed keywords

AMPHETAMINE; METENKEPHALIN; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; IMMUNE RESPONSE; IMMUNE SYSTEM; LIMBIC SYSTEM; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SENSITIZATION; SPLEEN; THYMUS;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM STIMULANTS; DIZOCILPINE MALEATE; DRUG ADMINISTRATION SCHEDULE; ENKEPHALIN, METHIONINE; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; MALE; NUCLEUS ACCUMBENS; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SPLEEN; TIME FACTORS;

EID: 63249083029     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.01.003     Document Type: Article

References (70)

1. Abarca C., Albrecht U., and Spanagel R. Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proc. Natl. Acad. Sci. USA 99 (2002) 9026-9030
2. Amenta F., Bronzetti E., Cantalamessa F., El-Assouad D., Felici L., Ricci A., and Tayebati S.K. Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes. J. Neuroimmunol. 117 (2001) 133-142
3. Assis M.A., Collino C., Figuerola Mde L., Sotomayor C., and Cancela L.M. Amphetamine triggers an increase in met-enkephalin simultaneously in brain areas and immune cells. J. Neuroimmunol. 178 (2006) 62-75
4. Assis M.A., Pacchioni A.M., Collino C., Paz M.C., Sotomayor C., Basso A.M., and Cancela L.M. A dopamine mechanism is implied in the acquisition and expression of amphetamine and stress-induced effects observed in the lymphocyte subpopulations. Eur. J. Pharmacol. 584 (2008) 405-414
5. Baldwin G.C., Roth M.D., and Tashkin D.P. Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J. Neuroimmunol. 83 (1998) 133-138
6. Bencsics A., Sershen H., Baranyi M., Hashim A., Lajtha A., and Vizi E.S. Dopamine, as well as norepinephrine, is a link between noradrenergic nerve terminals and splenocytes. Brain Res. 761 (1997) 236-243
7. Bergquist J., Tarkowski A., Ekman R., and Ewing A. Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc. Natl. Acad. Sci. USA 91 (1994) 12912-12916
8. Bernton E.W., Meltzer M.S., and Holaday J.W. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 239 4838 (1988) 401-404
9. Blandini F., Cosentino M., Mangiagalli A., Marino F., Samuele A., Rasini E., Fancellu R., Tassorelli C., Pacchetti C., Martignoni E., Riboldazzi G., Calandrella D., Lecchini S., Frigo G., and Nappi G. Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson's disease. The effect of dopaminergic treatment. J. Neural. Transm. 111 (2004) 1017-1030
10. Boldyrev A.A., Carpenter D.O., and Johnson P. Emerging evidence for a similar role of glutamate receptors in the nervous and immune systems. J. Neurochem. 95 (2005) 913-918
11. Boldyrev A.A., Kazey V.I., Leinsoo T.A., Mashkina A.P., Tyulina O.V., Johnson P., Tuneva J.O., Chittur S., and Carpenter D.O. Rodent lymphocytes express functionally active glutamate receptors. Biochem. Biophys. Res. Commun. 324 (2004) 133-139
12. Cador M., Bjijou Y., Cailhol S., and Stinus L. d-Amphetamine-induced behavioral sensitization: implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation. Neuroscience 94 (1999) 705-721
13. Carlezon Jr. W.A., and Nestler E.J. Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?. Trends Neurosci. 25 (2002) 610-615
14. Coligan J.E., Kruisbeek A.M., Margulies D.H., Shevach E.M., and Strober W. Measurement of proliferative response of cultured lymphocytes in immunologic studies in humans. In: Coico R. (Ed). Currents Protocols in Immunology (1999), John Wiley and Son Inc. 7.10.1 Chapter 7
15. Cosentino M., Zaffaroni M., Marino F., Bombelli R., Ferrari M., Rasini E., Lecchini S., Ghezzi A., and Frigo G. Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis. J. Neuroimmunol. 133 (2002) 233-240
16. Dudman J.T., Eaton M.E., Rajadhyaksha A., Macias W., Taher M., Barczak A., Kameyama K., Huganir R., and Konradi C. Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. J. Neurochem. 87 (2003) 922-934
17. Fitzgerald L.W., Ortiz J., Hamedani A.G., and Nestler E.J. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J. Neurosci. 16 (1996) 274-282
18. Friedman H., and Eisenstein T.K. Neurological basis of drug dependence and its effects on the immune system. J. Neuroimmunol. 147 (2004) 106-108
19. Fulford A.J., Harbuz M.S., and Jessop D.S. Antisense inhibition of pro-opiomelanocortin and proenkephalin A messenger RNA translation alters rat immune cell function in vitro. J. Neuroimmunol. 106 (2000) 6-13
20. Gordon J., and Barnes N.M. Lymphocytes transport serotonin and dopamine: agony or ecstasy?. Trends Immunol. 24 (2003) 438-443
21. Haas H.S., and Schauenstein K. Neuroimmunomodulation via limbic structures: the neuroanatomy of psychoimmunology. Prog. Neurobiol. 51 (1997) 195-222
22. Haus E., and Smolensky M.H. Biologic rhythms in the immune system. Chronobiol. Int. 16 (1999) 581-622
23. Howard A.A., Klein R.S., Schoenbaum E.E., and Gourevitch M.N. Crack cocaine use and other risk factors for tuberculin positivity in drug users. Clin. Infect. Dis. 35 (2002) 1183-1190
24. Kalivas P.W. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system. J. Pharmacol. Exp. Ther. 235 (1985) 544-550
25. Kalivas P.W. Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity. Dialogues Clin. Neurosci. 9 (2007) 389-397
26. Kalivas P.W., and Duffy P. A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J. Neurochem. 56 (1991) 961-967
27. Kalivas P.W., and Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Brain Res. Rev. 16 (1991) 223-244
28. Kauer J.A., and Malenka R.C. Synaptic plasticity and addiction. Nat. Rev. Neurosci. 8 (2007) 844-858
29. Kavelaars A., Cobelens P.M., Teunis M.A., and Heijnen C.J. Changes in innate and acquired immune responses in mice with targeted deletion of the dopamine transporter gene. J. Neuroimmunol. 161 (2005) 162-168
30. Kubera M., Filip M., Basta-Kaim A., Nowak E., Budziszewska B., Tetich M., Holan V., Korzeniak B., and Przegalinski E. The effect of amphetamine sensitization on mouse immunoreactivity. J. Physiol. Pharmacol. 53 (2002) 233-242
31. Kubera M., Filip M., Basta-Kaim A., Nowak E., Siwanowicz J., Zajicova A., Holan V., Maes M., and Lason W. The effect of cocaine sensitization on mouse immunoreactivity. Eur. J. Pharmacol. 483 (2004) 309-315
32. Kvetnansky R., Armando I., Weise V.K., Holmes C., Fukuhara K., Deka-Starosta A., Kopin I.J., and Goldstein D.S. Plasma dopa responses during stress: dependence on sympathoneural activity and tyrosine hydroxylation. J. Pharmacol. Exp. Ther. 261 (1992) 899-909
33. Ligeiro de Oliveira A.P., Fialho de Araujo A.M., Lazarini R., Silva Z.L., De Nucci G., and Muscará M.N. Effect of amphetamine on immune-mediated lung inflammatory response in rats. Neuroimmunomodulation 11 (2004) 181-190
34. Ligeiro de Oliveira A.P., Lazzarini R., Cavriani G., Quinteiro-Filho W.M., Tavares de Lima W., and Palermo-Neto J. Effects of single or repeated amphetamine treatment and withdrawal on lung allergic inflammation in rats. Int. Immunopharmacol. 8 (2008) 1164-1171
35. Liste I., Munoz A., Guerra M.J., and Labandeira-Garcia J.L. Fenfluramine-induced increase in preproenkephalin mRNA levels in the striatum: interaction between the serotonergic, glutamatergic, and dopaminergic systems. Synapse 35 (2000) 182-191
36. Lombardi G., Dianzani C., Miglio G., Canonico P.L., and Fantozzi R. Characterization of ionotropic glutamate receptors in human lymphocytes. Br. J. Pharmacol. 133 (2001) 936-944
37. Magendzo K., and Bustos G. Expression of amphetamine-induced behavioral sensitization after short- and long-term withdrawal periods: participation of mu- and delta-opioid receptors. Neuropsychopharmacology 28 (2003) 468-477
38. Mao L., and Wang J.Q. Contribution of ionotropic glutamate receptors to acute amphetamine-stimulated preproenkephalin mRNA expression in the rat striatum in vivo. Neurosci. Lett. 346 (2003) 17-20
39. Mathon D.S., Vanderschuren L.J., and Ramakers G.M. Reduced psychostimulant effects on dopamine dynamics in the nucleus accumbens of mu-opioid receptor knockout mice. Neuroscience 141 (2006) 1679-1684
40. McKenna F., McLaughlin P.J., Lewis B.J., Sibbring G.C., Cummerson J.A., Bowen-Jones D., and Moots R.J. Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J. Neuroimmunol. 132 (2002) 34-40
41. Mellon R.D., and Bayer B.M. Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action. J. Neuroimmunol. 83 (1998) 19-28
42. Nath A., Hauser K.F., Wojna V., Booze R.M., Maragos W., Prendergast M., Cass W., and Turchan J.T. Molecular basis for interactions of HIV and drugs of abuse. J. Acquir. Immune Defic. Syndr. 31 Suppl. 2 (2002) S62-S69
43. Pacchioni A.M., Cador M., Bregonzio C., and Cancela L.M. A glutamate-dopamine interaction in the persistent enhanced response to amphetamine in nucleus accumbens core but not shell following a single restraint stress. Neuropsychopharmacology 32 (2007) 682-692
44. Pacheco-López G., Niemi M.B., Kou W., Bildhauser A., Gross C.M., Goebel M.U., del Rey A., Besedovsky H.O., and Schedlowski M. Central catecholamine depletion inhibits peripheral lymphocyte responsiveness in spleen and blood. J. Neurochem. 86 (2003) 1024-1031
45. Pacheco R., Gallart T., Lluis C., and Franco R. Role of glutamate on T-cell mediated immunity. J. Neuroimmunol. 185 (2007) 9-19
46. Pacheco R., Oliva H., Martinez-Navio J.M., Climent N., Ciruela F., Gatell J.M., Gallart T., Mallol J., Lluis C., and Franco R. Glutamate released by dendritic cells as a novel modulator of T cell activation. J. Immunol. 177 (2006) 6695-6704
47. Pellegrino T., and Bayer B.M. In vivo effects of cocaine on immune cell function. J. Neuroimmunol. 83 (1998) 139-147
48. Pierce R.C., and Kalivas P.W. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J. Pharmacol. Exp. Ther. 275 (1995) 1019-1029
49. Pierce R.C., and Kalivas P.W. Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J. Neurosci. 17 (1997) 3254-3261
50. Piva M., Moreno J.I., Jenkins F.S., Smith J.K., Thomas J.L., Montgomery C., Wilson C.B., and Sizemore R.C. In vitro modulation of cytokine expression by enkephalin-derived peptides. Neuroimmunomodulation 12 (2005) 339-347
51. Prasad B.M., Ulibarri C., Kalivas P.W., and Sorg B.A. Effect of adrenalectomy on the initiation and expression of cocaine-induced sensitization. Psychopharmacology (Berl.) 125 (1996) 265-273
52. Rawls S.M., and McGinty J.F. Delta opioid receptors regulate calcium-dependent, amphetamine-evoked glutamate levels in the rat striatum: an in vivo microdialysis study. Brain Res. 861 (2000) 296-304
53. Rich J.D., Anderson B.J., Schwartzapfel B., and Stein M.D. Sexual risk for hepatitis B virus infection among hepatitis C virus-negative heroin and cocaine users. Epidemiol. Infect. 134 (2006) 478-484
54. Robinson T.E., and Berridge K.C. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95 Suppl. 2 (2000) S91-S117
55. Saha B., Mondal A.C., Majumder J., Basu S., and Dasgupta P.S. Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4+ and CD8+ T cells in vitro: a receptor-mediated mechanism. Neuroimmunomodulation 9 (2001) 23-33
56. Saravia F., Padros M.R., Ase A., Aloyz R., Duran S., and Vindrola O. Differential response to a stress stimulus of proenkephalin peptide content in immune cells of naive and chronically stressed rats. Neuropeptides 32 (1998) 351-359
57. Schmidt E.D., Tilders F.J., Binnekade R., Schoffelmeer A.N., and De Vries T.J. Stressor- or drug-induced sensitization of the corticosterone response is not critically involved in the long-term expression of behavioural sensitization to amphetamine. Neuroscience 92 (1999) 343-352
58. Sizemore R.C., Piva M., Moore L., Gordonov N., Heilman E., and Godfrey H.P. Modulation of delayed-type hypersensitivity responses in hairless guinea pigs by peptides derived from enkephalin. Neuroimmunomodulation 11 (2004) 141-148
59. Stanojevic S., Mitic K., Vujic V., Kovacevic-Jovanovic V., and Dimitrijevic M. The influence of stress and methionine-enkephalin on macrophage functions in two inbred rat strains. Life Sci. 80 (2007) 901-909
60. Ungless M.A., Whistler J.L., Malenka R.C., and Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411 (2001) 583-587
61. Van Loon G.R. Plasma dopamine: regulation and significance. Fed. Proc. 42 (1983) 3012-3018
62. Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl.) 151 (2000) 99-120
63. Vanderschuren L.J., Schmidt E.D., De Vries T.J., Van Moorsel C.A., Tilders F.J., and Schoffelmeer A.N. A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats. J. Neurosci. 19 (1999) 9579-9586
64. Vindrola O., Mayer A.M., Citera G., Spitzer J.A., and Espinoza L.R. Prohormone convertases PC2 and PC3 in rat neutrophils and macrophages. Parallel changes with proenkephalin-derived peptides induced by LPS in vivo. Neuropeptides 27 (1994) 235-244
65. Wang J.Q., and McGinty J.F. D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine. Synapse 22 (1996) 114-122
66. White F.J., and Wang R.Y. Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic d-amphetamine treatment. Brain Res. 309 (1984) 283-292
67. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54 (1998) 679-720
68. Wolf M.E., White F.J., and Hu X.T. Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system. Behav. Pharmacol. 4 (1993) 429-442
69. Wolf M.E., White F.J., and Hu X.T. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J. Neurosci. 14 (1994) 1735-1745
70. Wolf M.E., White F.J., Nassar R., Brooderson R.J., and Khansa M.R. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264 (1993) 249-255